Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration
Figure 2
Net health benefits accruing to patients with neovascular age-related macular degeneration when using vascular endothelial growth factor inhibitors according to age (years) at treatment initiation.